Effects of dextromethorphan on MDMA-induced serotonergic aberration in the brains of non-human primates using [ 123 I]-ADAM/SPECT

Kuo Hsing Ma, Tsung Ta Liu, Shao Ju Weng, Chien Fu F. Chen, Yuahn Sieh Huang, Sheau Huei Chueh, Mei Hsiu Liao, Kang Wei Chang, Chi Chang Sung, Te Hung Hsu, Wen Sheng Huang, Cheng Yi Cheng

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

3,4-Methylenedioxymethamphetamine (MDMA), a common recreational drug, is known to cause serotonergic neurotoxicity in the brain. Dextromethorphan (DM) is a widely used antitussive reported to exert anti-inflammatory effect in vivo. In this study, we examined the long-term effect of MDMA on the primate serotonergic system and the protective property of DM against MDMA-induced serotonergic abnormality using single photon emission computed tomography (SPECT). Nine monkeys (Macaca cyclopis) were divided into three groups, namely control, MDMA and co-treatment (MDMA/DM). [ 123 I]-ADAM was used as the radioligand for serotonin transporters (SERT) in SPECT scans. SERT levels of the brain were evaluated and presented as the uptake ratios (URs) of [ 123 I]-ADAM in several regions of interest of the brain including midbrain, thalamus and striatum. We found that the URs of [ 123 I]-ADAM were significantly lower in the brains of MDMA than control group, indicating lower brain SERT levels in the MDMA-treated monkeys. This MDMA-induced decrease in brain SERT levels could persist for over four years. However, the loss of brain SERT levels was not observed in co-treatment group. These results suggest that DM may exert a protective effect against MDMA-induced serotonergic toxicity in the brains of the non-human primate.

Original languageEnglish
Article number38695
JournalScientific Reports
Volume6
DOIs
Publication statusPublished - Dec 12 2016
Externally publishedYes

Fingerprint

Dextromethorphan
N-Methyl-3,4-methylenedioxyamphetamine
Single-Photon Emission-Computed Tomography
Primates
Serotonin Plasma Membrane Transport Proteins
Brain
Haplorhini
Antitussive Agents
Control Groups
Macaca
Street Drugs
Mesencephalon
Thalamus
Anti-Inflammatory Agents

ASJC Scopus subject areas

  • General

Cite this

Ma, K. H., Liu, T. T., Weng, S. J., Chen, C. F. F., Huang, Y. S., Chueh, S. H., ... Cheng, C. Y. (2016). Effects of dextromethorphan on MDMA-induced serotonergic aberration in the brains of non-human primates using [ 123 I]-ADAM/SPECT. Scientific Reports, 6, [38695]. https://doi.org/10.1038/srep38695

Effects of dextromethorphan on MDMA-induced serotonergic aberration in the brains of non-human primates using [ 123 I]-ADAM/SPECT. / Ma, Kuo Hsing; Liu, Tsung Ta; Weng, Shao Ju; Chen, Chien Fu F.; Huang, Yuahn Sieh; Chueh, Sheau Huei; Liao, Mei Hsiu; Chang, Kang Wei; Sung, Chi Chang; Hsu, Te Hung; Huang, Wen Sheng; Cheng, Cheng Yi.

In: Scientific Reports, Vol. 6, 38695, 12.12.2016.

Research output: Contribution to journalArticle

Ma, KH, Liu, TT, Weng, SJ, Chen, CFF, Huang, YS, Chueh, SH, Liao, MH, Chang, KW, Sung, CC, Hsu, TH, Huang, WS & Cheng, CY 2016, 'Effects of dextromethorphan on MDMA-induced serotonergic aberration in the brains of non-human primates using [ 123 I]-ADAM/SPECT', Scientific Reports, vol. 6, 38695. https://doi.org/10.1038/srep38695
Ma, Kuo Hsing ; Liu, Tsung Ta ; Weng, Shao Ju ; Chen, Chien Fu F. ; Huang, Yuahn Sieh ; Chueh, Sheau Huei ; Liao, Mei Hsiu ; Chang, Kang Wei ; Sung, Chi Chang ; Hsu, Te Hung ; Huang, Wen Sheng ; Cheng, Cheng Yi. / Effects of dextromethorphan on MDMA-induced serotonergic aberration in the brains of non-human primates using [ 123 I]-ADAM/SPECT. In: Scientific Reports. 2016 ; Vol. 6.
@article{12bc1d33073146fc816a697bb775eb35,
title = "Effects of dextromethorphan on MDMA-induced serotonergic aberration in the brains of non-human primates using [ 123 I]-ADAM/SPECT",
abstract = "3,4-Methylenedioxymethamphetamine (MDMA), a common recreational drug, is known to cause serotonergic neurotoxicity in the brain. Dextromethorphan (DM) is a widely used antitussive reported to exert anti-inflammatory effect in vivo. In this study, we examined the long-term effect of MDMA on the primate serotonergic system and the protective property of DM against MDMA-induced serotonergic abnormality using single photon emission computed tomography (SPECT). Nine monkeys (Macaca cyclopis) were divided into three groups, namely control, MDMA and co-treatment (MDMA/DM). [ 123 I]-ADAM was used as the radioligand for serotonin transporters (SERT) in SPECT scans. SERT levels of the brain were evaluated and presented as the uptake ratios (URs) of [ 123 I]-ADAM in several regions of interest of the brain including midbrain, thalamus and striatum. We found that the URs of [ 123 I]-ADAM were significantly lower in the brains of MDMA than control group, indicating lower brain SERT levels in the MDMA-treated monkeys. This MDMA-induced decrease in brain SERT levels could persist for over four years. However, the loss of brain SERT levels was not observed in co-treatment group. These results suggest that DM may exert a protective effect against MDMA-induced serotonergic toxicity in the brains of the non-human primate.",
author = "Ma, {Kuo Hsing} and Liu, {Tsung Ta} and Weng, {Shao Ju} and Chen, {Chien Fu F.} and Huang, {Yuahn Sieh} and Chueh, {Sheau Huei} and Liao, {Mei Hsiu} and Chang, {Kang Wei} and Sung, {Chi Chang} and Hsu, {Te Hung} and Huang, {Wen Sheng} and Cheng, {Cheng Yi}",
year = "2016",
month = "12",
day = "12",
doi = "10.1038/srep38695",
language = "English",
volume = "6",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Effects of dextromethorphan on MDMA-induced serotonergic aberration in the brains of non-human primates using [ 123 I]-ADAM/SPECT

AU - Ma, Kuo Hsing

AU - Liu, Tsung Ta

AU - Weng, Shao Ju

AU - Chen, Chien Fu F.

AU - Huang, Yuahn Sieh

AU - Chueh, Sheau Huei

AU - Liao, Mei Hsiu

AU - Chang, Kang Wei

AU - Sung, Chi Chang

AU - Hsu, Te Hung

AU - Huang, Wen Sheng

AU - Cheng, Cheng Yi

PY - 2016/12/12

Y1 - 2016/12/12

N2 - 3,4-Methylenedioxymethamphetamine (MDMA), a common recreational drug, is known to cause serotonergic neurotoxicity in the brain. Dextromethorphan (DM) is a widely used antitussive reported to exert anti-inflammatory effect in vivo. In this study, we examined the long-term effect of MDMA on the primate serotonergic system and the protective property of DM against MDMA-induced serotonergic abnormality using single photon emission computed tomography (SPECT). Nine monkeys (Macaca cyclopis) were divided into three groups, namely control, MDMA and co-treatment (MDMA/DM). [ 123 I]-ADAM was used as the radioligand for serotonin transporters (SERT) in SPECT scans. SERT levels of the brain were evaluated and presented as the uptake ratios (URs) of [ 123 I]-ADAM in several regions of interest of the brain including midbrain, thalamus and striatum. We found that the URs of [ 123 I]-ADAM were significantly lower in the brains of MDMA than control group, indicating lower brain SERT levels in the MDMA-treated monkeys. This MDMA-induced decrease in brain SERT levels could persist for over four years. However, the loss of brain SERT levels was not observed in co-treatment group. These results suggest that DM may exert a protective effect against MDMA-induced serotonergic toxicity in the brains of the non-human primate.

AB - 3,4-Methylenedioxymethamphetamine (MDMA), a common recreational drug, is known to cause serotonergic neurotoxicity in the brain. Dextromethorphan (DM) is a widely used antitussive reported to exert anti-inflammatory effect in vivo. In this study, we examined the long-term effect of MDMA on the primate serotonergic system and the protective property of DM against MDMA-induced serotonergic abnormality using single photon emission computed tomography (SPECT). Nine monkeys (Macaca cyclopis) were divided into three groups, namely control, MDMA and co-treatment (MDMA/DM). [ 123 I]-ADAM was used as the radioligand for serotonin transporters (SERT) in SPECT scans. SERT levels of the brain were evaluated and presented as the uptake ratios (URs) of [ 123 I]-ADAM in several regions of interest of the brain including midbrain, thalamus and striatum. We found that the URs of [ 123 I]-ADAM were significantly lower in the brains of MDMA than control group, indicating lower brain SERT levels in the MDMA-treated monkeys. This MDMA-induced decrease in brain SERT levels could persist for over four years. However, the loss of brain SERT levels was not observed in co-treatment group. These results suggest that DM may exert a protective effect against MDMA-induced serotonergic toxicity in the brains of the non-human primate.

UR - http://www.scopus.com/inward/record.url?scp=85005965418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85005965418&partnerID=8YFLogxK

U2 - 10.1038/srep38695

DO - 10.1038/srep38695

M3 - Article

C2 - 27941910

AN - SCOPUS:85005965418

VL - 6

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 38695

ER -